Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

SBRT showed improved LPFS over RFA in treating single recurrent small HCC, especially for tumors ≤2 cm. Both SBRT and RFA demonstrated similar PFS, OS, and safety profiles, with mild to moderate side ...

A short course of androgen deprivation therapy (ADT) added to stereotactic body radiotherapy (SBRT) halved the risk of ...

Phase 2 data support the use of SBRT in patients with CRPC who have 1-5 metastatic sites, according to researchers.

Adding stereotactic body radiotherapy to enzalutamide and ADT for oligometastatic castration-resistant prostate cancer prolongs radiographic progression-free survival. Adding metastasis-directed ...

The UAB Department of Radiation Oncology has partnered with Varian to develop a three-day conference that discusses and demonstrates stereotactic radiation (SRS) and stereotactic body radiation (SBRT) ...